Nuvation Bio, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNew York, NY
US patents18
SAM.gov UEIZF4GX9YEQE24
CAGE code116R5
Incorporated inDE
LEI2549009IT4XP2SCZTR55
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
18 US patents granted 2020–2025, 18 of them in the five years to SEP 2025.
Organic fine chemistry 10Pharmaceuticals 8
- Anti-cancer nuclear hormone receptor-targeting compoundsUS 12,398,121 · granted AUG 26, 2025
- Anti-cancer nuclear hormone receptor-targeting compoundsUS 12,208,141 · granted JAN 28, 2025
- Anti-cancer nuclear hormone receptor-targeting compoundsUS 12,006,314 · granted JUN 11, 2024
- Anti-cancer nuclear hormone receptor-targeting compoundsUS 11,952,349 · granted APR 9, 2024
- Anti-cancer nuclear hormone receptor-targeting compoundsUS 11,834,458 · granted DEC 5, 2023
Newest 5 shown · Granted to Nuvation Bio INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Nuvation Bio, INC. | New York | NY | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.